Could an asthma drug help fight lung cancer? early trial investigates
NCT ID NCT07675876
First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time
Summary
This pilot study tests whether an inhaled drug called cromolyn sodium, already used for asthma, is safe and feasible for people with locally advanced lung cancer. The drug works by calming mast cells, which may play a role in tumor growth and treatment resistance. About 5 to 10 participants will receive the drug via a dry powder inhaler and be monitored for side effects, tumor changes, and other health markers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
cromolyn sodium (inhaled)
What this could lead to
If successful, this could point toward a new way to treat lung cancer by calming inflammation in the tumor environment.
What could go wrong
This is a very early, small pilot study with only 10 people. It is designed mainly to check safety, not to prove the drug works against cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
In home ttreatment
Denver, Colorado, 80220-4425, United States
-
Treated at home
Denver, Colorado, 80220-4425, United States